Schedule 13D ownership disclosure

Neuronetics Inc

Common Stock, par value $0.01 per share · CUSIP: 64131A105

Event date: 2026-03-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MADRYN ASSET MANAGEMENT, LPReported CIK 0001787423

    Shares: 20,737,061 · Class: 30.3%

  • MADRYN HEALTH PARTNERS II, LP

    Shares: 1,430,953 · Class: 2.1%

  • MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP

    Shares: 17,044,940 · Class: 24.9%

  • MADRYN HEALTH ADVISORS II, LP

    Shares: 18,475,893 · Class: 27.0%

  • MADRYN HEALTH ADVISORS GP II, LLC

    Shares: 18,475,893 · Class: 27.0%

  • MADRYN SELECT OPPORTUNITIES, LP

    Shares: 2,261,168 · Class: 3.3%

  • MADRYN SELECT ADVISORS, LP

    Shares: 2,261,168 · Class: 3.3%

  • MADRYN SELECT ADVISORS GP, LLC

    Shares: 2,261,168 · Class: 3.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-091919
Form type
SCHEDULE 13D/A
Filer
Madryn Asset Management, LP
CIK
CIK 1787423
Filed
Mar 04, 2026
Reporting period
Mar 02, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub